The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression

  1. Medina-Herrera, A.
  2. Vazquez, I.
  3. Cuenca, I.
  4. Rosa-Rosa, J.M.
  5. Ariceta, B.
  6. Jimenez, C.
  7. Fernandez-Mercado, M.
  8. Larrayoz, M.J.
  9. Gutierrez, N.C.
  10. Fernandez-Guijarro, M.
  11. Gonzalez-Calle, V.
  12. Rodriguez-Otero, P.
  13. Oriol, A.
  14. Rosiñol, L.
  15. Alegre, A.
  16. Escalante, F.
  17. De La Rubia, J.
  18. Teruel, A.I.
  19. De Arriba, F.
  20. Hernandez, M.T.
  21. Lopez-Jimenez, J.
  22. Ocio, E.M.
  23. Puig, N.
  24. Paiva, B.
  25. Lahuerta, J.J.
  26. Bladé, J.
  27. San Miguel, J.F.
  28. Mateos, M.V.
  29. Martinez-Lopez, J.
  30. Calasanz, M.J.
  31. Garcia-Sanz, R.
  32. Show all authors +
Journal:
Blood cancer journal

ISSN: 2044-5385

Year of publication: 2024

Volume: 14

Issue: 1

Pages: 74

Type: Article

DOI: 10.1038/S41408-024-01053-3 GOOGLE SCHOLAR lock_openOpen access editor